Exact Mass: 477.2012
Exact Mass Matches: 477.2012
Found 500 metabolites which its exact mass value is equals to given mass value 477.2012
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Furcelleran
Furcelleran is an emulsifier, stabiliser, thickening agent. Furcelleran salts prepd. by increasing the concentration of the naturally occurring cations (ammonium, calcium, potassium or sodium) have similar utility. Emulsifier, stabiliser, thickening agent. Furcelleran salts prepd. by increasing the concentration of the naturally occurring cations (ammonium, calcium, potassium or sodium) have similar utility
(2S,3R)-2-(4-{2-[(3S,4S)-3,4-Dimethylpyrrolidin-1-YL]ethoxy}phenyl)-3-(4-hydroxyphenyl)-2,3-dihydro-1,4-benzoxathiin-6-OL
5-O-Benzyl 3-O-ethyl 2-methyl-6-phenyl-4-(2-phenylethynyl)-3,4-dihydropyridine-3,5-dicarboxylate
1-Methyl-4-[1-methyl-4-(alpha,4-dimethoxybenzyl)-5-(4-methoxybenzyl)-1H-imidazole-2-ylamino]-2,5-dihydro-1H-imidazole-2,5-dione
Ala Ala Met Trp
Ala Ala Trp Met
Ala Cys Glu Arg
Ala Cys Arg Glu
Ala Cys Val Trp
Ala Cys Trp Val
Ala Glu Cys Arg
Ala Glu Met Gln
Ala Glu Gln Met
Ala Glu Arg Cys
Ala His His Asn
Ala His Asn His
Ala Met Ala Trp
Ala Met Glu Gln
Ala Met Gln Glu
Ala Met Trp Ala
Ala Asn His His
Ala Gln Glu Met
Ala Gln Met Glu
Ala Arg Cys Glu
Ala Arg Glu Cys
Ala Val Cys Trp
Ala Val Trp Cys
Ala Trp Ala Met
Ala Trp Cys Val
Ala Trp Met Ala
Ala Trp Val Cys
Cys Ala Glu Arg
Cys Ala Arg Glu
Cys Ala Val Trp
Cys Ala Trp Val
Cys Asp Ile Gln
Cys Asp Leu Gln
Cys Asp Gln Ile
Cys Asp Gln Leu
Cys Glu Ala Arg
Cys Glu Ile Asn
Cys Glu Leu Asn
Cys Glu Asn Ile
Cys Glu Asn Leu
Cys Glu Gln Val
Cys Glu Arg Ala
Cys Glu Val Gln
Cys Gly Ile Trp
Cys Gly Leu Trp
Cys Gly Trp Ile
Cys Gly Trp Leu
Cys Ile Asp Gln
Cys Ile Glu Asn
Cys Ile Gly Trp
Cys Ile Asn Glu
Cys Ile Gln Asp
Cys Ile Trp Gly
Cys Lys Met Pro
Cys Lys Asn Asn
Cys Lys Pro Met
Cys Leu Asp Gln
Cys Leu Glu Asn
Cys Leu Gly Trp
Cys Leu Asn Glu
Cys Leu Gln Asp
Cys Leu Trp Gly
Cys Met Lys Pro
Cys Met Pro Lys
Cys Asn Glu Ile
Cys Asn Glu Leu
Cys Asn Ile Glu
Cys Asn Lys Asn
Cys Asn Leu Glu
Cys Asn Asn Lys
Cys Pro Lys Met
Cys Pro Met Lys
Cys Gln Asp Ile
Cys Gln Asp Leu
Cys Gln Glu Val
Cys Gln Ile Asp
Cys Gln Leu Asp
Cys Gln Val Glu
Cys Arg Ala Glu
Cys Arg Glu Ala
Cys Val Ala Trp
Cys Val Glu Gln
Cys Val Gln Glu
Cys Val Trp Ala
Cys Trp Ala Val
Cys Trp Gly Ile
Cys Trp Gly Leu
Cys Trp Ile Gly
Cys Trp Leu Gly
Cys Trp Val Ala
Asp Cys Ile Gln
Asp Cys Leu Gln
Asp Cys Gln Ile
Asp Cys Gln Leu
Asp Asp Lys Thr
Asp Asp Thr Lys
Asp Glu Lys Ser
Asp Glu Ser Lys
Asp Gly Met Arg
Asp Gly Arg Met
Asp Ile Cys Gln
Asp Ile Gln Cys
Asp Lys Asp Thr
Asp Lys Glu Ser
Asp Lys Ser Glu
Asp Lys Thr Asp
Asp Leu Cys Gln
Asp Leu Gln Cys
Asp Met Gly Arg
Asp Met Asn Val
Asp Met Arg Gly
Asp Met Val Asn
Asp Asn Met Val
Asp Asn Val Met
Asp Gln Cys Ile
Asp Gln Cys Leu
Asp Gln Ile Cys
Asp Gln Leu Cys
Asp Arg Gly Met
Asp Arg Met Gly
Asp Ser Glu Lys
Asp Ser Lys Glu
Asp Thr Asp Lys
Asp Thr Lys Asp
Asp Val Met Asn
Asp Val Asn Met
Glu Ala Cys Arg
Glu Ala Met Gln
Glu Ala Gln Met
Glu Ala Arg Cys
Glu Cys Ala Arg
Glu Cys Ile Asn
Glu Cys Leu Asn
Glu Cys Asn Ile
Glu Cys Asn Leu
Glu Cys Gln Val
Glu Cys Arg Ala
Glu Cys Val Gln
Glu Asp Lys Ser
Glu Asp Ser Lys
Glu Ile Cys Asn
Glu Ile Asn Cys
Glu Lys Asp Ser
Glu Lys Ser Asp
Glu Leu Cys Asn
Glu Leu Asn Cys
Glu Met Ala Gln
Glu Met Gln Ala
Glu Asn Cys Ile
Glu Asn Cys Leu
Glu Asn Ile Cys
Glu Asn Leu Cys
Glu Gln Ala Met
Glu Gln Cys Val
Glu Gln Met Ala
Glu Gln Thr Thr
Glu Gln Val Cys
Glu Arg Ala Cys
Glu Arg Cys Ala
Glu Ser Asp Lys
Glu Ser Lys Asp
Glu Thr Gln Thr
Glu Thr Thr Gln
Glu Val Cys Gln
Glu Val Gln Cys
Gly Cys Ile Trp
Gly Cys Leu Trp
Gly Cys Trp Ile
Gly Cys Trp Leu
Gly Asp Met Arg
Gly Asp Arg Met
Gly His His Gln
Gly His Gln His
Gly Ile Cys Trp
Gly Ile Trp Cys
Gly Leu Cys Trp
Gly Leu Trp Cys
Gly Met Asp Arg
Gly Met Arg Asp
Gly Gln His His
Gly Arg Asp Met
Gly Arg Met Asp
3,5-Pyridinedicarboxylic acid, 2,6-dimethyl-4-(3-nitrophenyl)-, methyl 2-[methyl(phenylmethyl)amino]
Gly Trp Cys Ile
Gly Trp Cys Leu
Gly Trp Ile Cys
Gly Trp Leu Cys
His Ala His Asn
His Ala Asn His
His Gly His Gln
His Gly Gln His
His His Ala Asn
His His Gly Gln
His His Asn Ala
His His Gln Gly
His Asn Ala His
His Asn His Ala
His Gln Gly His
His Gln His Gly
Ile Cys Asp Gln
Ile Cys Glu Asn
Ile Cys Gly Trp
Ile Cys Asn Glu
Ile Cys Gln Asp
Ile Cys Trp Gly
Ile Asp Cys Gln
Ile Asp Gln Cys
Ile Glu Cys Asn
Ile Glu Asn Cys
Ile Gly Cys Trp
Ile Gly Trp Cys
Ile Asn Cys Glu
Ile Asn Glu Cys
Ile Gln Cys Asp
Ile Gln Asp Cys
Ile Trp Cys Gly
Ile Trp Gly Cys
Lys Cys Met Pro
Lys Cys Asn Asn
Lys Cys Pro Met
Lys Asp Asp Thr
Lys Asp Glu Ser
Lys Asp Ser Glu
Lys Asp Thr Asp
Lys Glu Asp Ser
Lys Glu Ser Asp
Lys Met Cys Pro
Lys Met Pro Cys
Lys Asn Cys Asn
Lys Asn Asn Cys
Lys Pro Cys Met
Lys Pro Met Cys
Lys Ser Asp Glu
Lys Ser Glu Asp
Lys Thr Asp Asp
Leu Cys Asp Gln
Leu Cys Glu Asn
Leu Cys Gly Trp
Leu Cys Asn Glu
Leu Cys Gln Asp
Leu Cys Trp Gly
Leu Asp Cys Gln
Leu Asp Gln Cys
Leu Glu Cys Asn
Leu Glu Asn Cys
Leu Gly Cys Trp
Leu Gly Trp Cys
Leu Asn Cys Glu
Leu Asn Glu Cys
Leu Gln Cys Asp
Leu Gln Asp Cys
Leu Trp Cys Gly
Leu Trp Gly Cys
Met Ala Ala Trp
Met Ala Glu Gln
Met Ala Gln Glu
Met Ala Trp Ala
Met Cys Lys Pro
Met Cys Pro Lys
Met Asp Gly Arg
Met Asp Asn Val
Met Asp Arg Gly
Met Asp Val Asn
Met Glu Ala Gln
Met Glu Gln Ala
Met Gly Asp Arg
Met Gly Arg Asp
Met Lys Cys Pro
Met Lys Pro Cys
Met Asn Asp Val
Met Asn Val Asp
Met Pro Cys Lys
Met Pro Lys Cys
Met Gln Ala Glu
Met Gln Glu Ala
Met Arg Asp Gly
Met Arg Gly Asp
Met Val Asp Asn
Met Val Asn Asp
Met Trp Ala Ala
Asn Ala His His
Asn Cys Glu Ile
Asn Cys Glu Leu
Asn Cys Ile Glu
Asn Cys Lys Asn
Asn Cys Leu Glu
Asn Cys Asn Lys
Asn Asp Met Val
Asn Asp Val Met
Asn Glu Cys Ile
Asn Glu Cys Leu
Asn Glu Ile Cys
Asn Glu Leu Cys
Asn His Ala His
Asn His His Ala
Asn Ile Cys Glu
Asn Ile Glu Cys
Asn Lys Cys Asn
Asn Lys Asn Cys
Asn Leu Cys Glu
Asn Leu Glu Cys
Asn Met Asp Val
Asn Met Val Asp
Asn Asn Cys Lys
Asn Asn Lys Cys
Asn Val Asp Met
Asn Val Met Asp
Pro Cys Lys Met
Pro Cys Met Lys
Pro Lys Cys Met
Pro Lys Met Cys
Pro Met Cys Lys
Pro Met Lys Cys
Gln Ala Glu Met
Gln Ala Met Glu
Gln Cys Asp Ile
Gln Cys Asp Leu
Gln Cys Glu Val
Gln Cys Ile Asp
Gln Cys Leu Asp
Gln Cys Val Glu
Gln Asp Cys Ile
Gln Asp Cys Leu
Gln Asp Ile Cys
Gln Asp Leu Cys
Gln Glu Ala Met
Gln Glu Cys Val
Gln Glu Met Ala
Gln Glu Thr Thr
Gln Glu Val Cys
Gln Gly His His
Gln His Gly His
Gln His His Gly
Gln Ile Cys Asp
Gln Ile Asp Cys
Gln Leu Cys Asp
Gln Leu Asp Cys
Gln Met Ala Glu
Gln Met Glu Ala
Gln Thr Glu Thr
Gln Thr Thr Glu
Gln Val Cys Glu
Gln Val Glu Cys
Arg Ala Cys Glu
Arg Ala Glu Cys
Arg Cys Ala Glu
Arg Cys Glu Ala
Arg Asp Gly Met
Arg Asp Met Gly
Arg Glu Ala Cys
Arg Glu Cys Ala
Arg Gly Asp Met
Arg Gly Met Asp
Arg Met Asp Gly
Arg Met Gly Asp
Ser Asp Glu Lys
Ser Asp Lys Glu
Ser Glu Asp Lys
Ser Glu Lys Asp
Ser Lys Asp Glu
Ser Lys Glu Asp
Thr Asp Asp Lys
Thr Asp Lys Asp
Thr Glu Gln Thr
Thr Glu Thr Gln
Thr Lys Asp Asp
Thr Gln Glu Thr
Thr Gln Thr Glu
Thr Thr Glu Gln
Thr Thr Gln Glu
Val Ala Cys Trp
Val Ala Trp Cys
Val Cys Ala Trp
Val Cys Glu Gln
Val Cys Gln Glu
Val Cys Trp Ala
Val Asp Met Asn
Val Asp Asn Met
Val Glu Cys Gln
Val Glu Gln Cys
Val Met Asp Asn
Val Met Asn Asp
Val Asn Asp Met
Val Asn Met Asp
Val Gln Cys Glu
Val Gln Glu Cys
Val Trp Ala Cys
Val Trp Cys Ala
Trp Ala Ala Met
Trp Ala Cys Val
Trp Ala Met Ala
Trp Ala Val Cys
Trp Cys Ala Val
Trp Cys Gly Ile
Trp Cys Gly Leu
Trp Cys Ile Gly
Trp Cys Leu Gly
Trp Cys Val Ala
Trp Gly Cys Ile
Trp Gly Cys Leu
Trp Gly Ile Cys
Trp Gly Leu Cys
Trp Ile Cys Gly
Trp Ile Gly Cys
Trp Leu Cys Gly
Trp Leu Gly Cys
Trp Met Ala Ala
Trp Val Ala Cys
Trp Val Cys Ala
furcelleran
Vilazodone Hydrochloride
D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017367 - Selective Serotonin Reuptake Inhibitors D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent C78272 - Agent Affecting Nervous System > C47794 - Serotonin Agonist D049990 - Membrane Transport Modulators Vilazodone Hydrochloride (EMD 68843 Hydrochloride) is a serotonin transporter (SER) inhibitor and 5-HT1A receptor partial agonist.
TERT-BUTYL 3-(4-(BENZYLOXY)BUTYL)-5-(3,4,5-TRIFLUOROPHENYL)-2H-1,4-OXAZINE-4(3H)-CARBOXYLATE
Native Electrophorus electricus (electric eel) Acetylcholinesterase
5-Benzyl 3-ethyl 2-methyl-6-phenyl-4-(phenylethynyl)-1,4-dihydro-3,5-pyridinedicarboxylate
O3-ethyl O5-(phenylmethyl) 2-methyl-6-phenyl-4-(2-phenylethynyl)-1,4-dihydropyridine-3,5-dicarboxylate
MRS-1191 is a potent and selective A3 adenosine receptor antagonist with a KB value of 92 nM, a Ki value of 31.4 nM for human A3 receptor and an IC50 of 120 nM for CHO cells[1]. MRS-1191 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
N-{(1s,2r)-1-Benzyl-3-[(Cyclopropylmethyl)(2-Furylsulfonyl)amino]-2-Hydroxypropyl}-N-Methylsuccinamide
(2S,3S)-2-[4-[2-[(3R,4R)-3,4-dimethylpyrrolidin-1-yl]ethoxy]phenyl]-3-(4-hydroxyphenyl)-2,3-dihydro-1,4-benzoxathiin-6-ol
7-[(2-hydroxyphenyl)methyl-methylamino]-1,2,3,10-tetramethoxy-6,7-dihydro-5H-benzo[a]heptalen-9-one
3-[4-(1,4-dioxa-8-azaspiro[4.5]decan-8-yl)-4-oxobutyl]-6,7-diethoxy-2-sulfanylidene-1H-quinazolin-4-one
4-Nitrophenyl 4-(bis(4-methoxyphenyl)methyl)piperazine-1-carboxylate
N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-methoxybenzenesulfonamide
17beta-hydroxy-2-methoxyestra-1,3,5(10)-trien-3-yl beta-D-glucopyranosiduronate
17beta-hydroxy-4-methoxyestra-1,3,5(10)-trien-3-yl beta-D-glucopyranosiduronate
N-[[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-prop-1-enyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N,1-dimethylimidazole-4-sulfonamide
N-[[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-prop-1-enyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N,1-dimethylimidazole-4-sulfonamide
N-[[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-prop-1-enyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N,1-dimethylimidazole-4-sulfonamide
N-[[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-prop-1-enyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N,1-dimethylimidazole-4-sulfonamide
N-[[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-prop-1-enyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N,1-dimethylimidazole-4-sulfonamide
N-[[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-prop-1-enyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N,1-dimethylimidazole-4-sulfonamide
N-[[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-prop-1-enyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N,1-dimethylimidazole-4-sulfonamide
N-[[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-prop-1-enyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N,1-dimethylimidazole-4-sulfonamide
N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-methoxybenzenesulfonamide
N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-methoxybenzenesulfonamide
N-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(4-phenyl-1-piperazinyl)ethyl]-3-oxanyl]-1-methyl-4-imidazolesulfonamide
2-[(2R,4aS,12aS)-8-[[(4-cyanoanilino)-oxomethyl]amino]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-methylacetamide
2-cyclopropyl-1-[(1S)-2-[(3-fluorophenyl)-oxomethyl]-1-(hydroxymethyl)-7-methoxy-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]ethanone
2-cyclopropyl-1-[(1R)-2-[(3-fluorophenyl)-oxomethyl]-1-(hydroxymethyl)-7-methoxy-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]ethanone
N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-methoxybenzenesulfonamide
N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-methoxybenzenesulfonamide
N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-methoxybenzenesulfonamide
N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(4-phenyl-1-piperazinyl)ethyl]-3-oxanyl]-1-methyl-4-imidazolesulfonamide
N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(4-phenyl-1-piperazinyl)ethyl]-3-oxanyl]-1-methyl-4-imidazolesulfonamide
N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(4-phenyl-1-piperazinyl)ethyl]-3-oxanyl]-1-methyl-4-imidazolesulfonamide
N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(4-phenyl-1-piperazinyl)ethyl]-3-oxanyl]-1-methyl-4-imidazolesulfonamide
N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(4-phenyl-1-piperazinyl)ethyl]-3-oxanyl]-1-methyl-4-imidazolesulfonamide
[(8R,9S,10R)-6-(2-methylphenyl)sulfonyl-9-[4-(3-pyridinyl)phenyl]-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
spectinabilin
A polyketide that is deoxyspectinabilin in which the tetramethyldeca-tetraen-1-yl chain attached to the 4-pyranone moiety has undergone oxidation at position 1 and at the methyl group at position 3 to afford the corresponding tetrahydrofuranyl moiety. Produced by Streptomyces spectabilis, it exhibits antiviral and antimalarial activity.
2-methoxy-17beta-estradiol 3-O-(beta-D-glucuronide)(1-)
A steroid glucuronide anion that is the conjugate base of 2-methoxy-17beta-estradiol 3-O-(beta-D-glucuronide) arising from deprotonation of the carboxylic acid function; major species at pH 7.3.